We will quote to you the news of the best health sites Like : "indiatimes" and the most famous medical experts : Divya Rajagopal
daily : 2016-12-28 & on time : 7:55
as declared in
Activists cry foul over new HIV drug monopoly
image uploaded by "indiatimes" site
MUMBAI: Doctors and aid organisations have called upon the Competition Commission of India and the price regulator to step in to ward off the monopoly over a new HIV drug, dolutegravir, which received the approval of the Indian drug controller last month.Dolutegravir — sold by GlaxoSmithKline's Viiv Healthcare unit under the Trivicay brand — is considered the best-in-class HIV drug as it reduces virus levels faster and has a high barrier to resistance compared to previous line of drugs.However, only one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market , because of a licensing agreement with Viiv Healthcare under the Medicine Patent Pool.This is despite Indian generic makers like Cipla Aurobindo Pharma , Hetero and Strides Arcolab having licence to sell this drug in nearly 50 other low- and middle-income countries.However, these companies can sell the drug through public sector tenders or through NGOs in India.Activists call this condition restrictive and anticompetitive.
about the details read more from here
Better‚ safer‚ cheaper: the new HIV treatment about to undergo full-scale tests in SA
image uploaded by "timeslive" site
In the best-case scenario‚ by 2019 two new drug combinations could treat an additional 2-million people without an increase in cost.Writing in the January issue of the SA Medical Journal‚ 23 experts express excitement about the possibilities of the study - dubbed Advance - which will involve 1,100 participants over 96 weeks."In an age of escalating medical costs‚ we are seldom presented with a win-win scenario with regard to clinical care‚" they say.
about the details read more from here
Scientists proffer new method to weaken HIV
image uploaded by "naija247news" site
Though the symptoms of Acquired Immuno Deficiency Syndrome (AIDS) can be controlled with a cocktail of anti-retroviral drugs, the disease, caused by the Human Immunodeficiency Virus, or HIV, does not have a permanent cure as yet.The treatment of AIDS, however, has got a major boost with scientists from Bengaluru reporting in a study that if the mutation rate of HIV virus is increased by two to six times, it could become ineffective against its host/human body in 10 years.Lead researcher Narendra Dixit, however, cautions that by increasing the mutation rate, such a person will not get cured, but their findings reveal how long it will take for the virus to become non-infectious, and the disease non-progressive.
about the details read more from here
To follow all the new news about
No comments:
Post a Comment